This site is intended for healthcare professionals only.

Techniques for Implementing Continuous Glucose Monitoring in Primary Care

Do you know how continuous glucose monitoring (CGM) can help you optimize diabetes management and improve patient outcomes in primary care settings?

Learn from our experts as they discuss the clinical landscape of CGM technology, how to interpret and apply data readouts to inform clinical decisions, what makes a good candidate for CGM, and expert insights on optimal patient education and communication.

CME available

1.5 AMA PRA Category 1 Credits™ available (look for the badge)

Interested in learning more? Listen to Dr. Jennifer Green as she discusses the activities and goals of this CME program.

Register now

Learning Objectives

Following completion of this independent educational program, you will be able to: 

  • Evaluate available CGM technologies, patients who are appropriate candidates for such CGM devices, and updates on insurance coverage 
  • Analyze patient CGM data and how such readouts can inform clinical decision making 
  • Adapt patient education and shared decision-making tools when evaluating barriers to CGM usage and adherence 

About the Program

This comprehensive educational program includes CME-accredited interactive infographics, which will be updated quarterly and supplemented by four video podcasts to help you stay abreast of the quick-changing CGM landscape. In addition, CME-accredited social media tutorials will highlight and dive deeper into hot topics in the CGM landscape and 2024 Advanced Technologies & Treatment for Diabetes (ATTD), American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD) conferences.

Target Audience

This program is aimed at US-based primary care physicians (PCPs) who are looking to improve their knowledge and skills in CGM technology for patients with type 2 diabetes (T2D).

Program Activities

Interactive Infographics

Close-up of doctor at hospital working with tablet © BillionPhotos.com/stock.adobe.com
CME available

Explore interactive infographics to dive deeper into the clinical landscape of CGM technology in primary care, including ambulatory glucose profile (AGP) interpretation, candidate selection, and patient education strategies.

  • Earn up to 0.75 AMA PRA Category 1 Credits™
Get started

Tutorials

Doctor holding mobile phone © C Malambo/peopleimages.com/stock.adobe.com
CME available

Join tutorials where experts break down important updates to the CGM landscape and discuss CGM insurance coverage changes, all while examining the clinical implications for managing patients with T2D.

  • Earn up to 0.75 AMA PRA Category 1 Credits™
Get started

Video Podcasts

Man wearing headphones © Anton/stock.adobe.comm

Listen to our experts as they dive into breaking news and clinical implications of data from the 2024 ATTD, ADA, and EASD conferences, and updates from the ADA’s 2025 Standards of Care.

Get started

Learning Objectives

Following completion of this independent educational program, you will be able to: 


  • Evaluate available CGM technologies, patients who are appropriate candidates for such CGM devices, and updates on insurance coverage
  • Analyze patient CGM data and how such readouts can inform clinical decision making
  • Adapt patient education and shared decision-making tools when evaluating barriers to CGM usage and adherence

About the Program

This comprehensive educational program includes CME-accredited interactive infographics, which will be updated quarterly and supplemented by four video podcasts to help you stay abreast of the quick-changing CGM landscape. In addition, CME-accredited social media tutorials will highlight and dive deeper into hot topics in the CGM landscape and 2024 Advanced Technologies & Treatment for Diabetes (ATTD), American Diabetes Association (ADA), European Association for the Study of Diabetes (EASD) conferences.

Target Audience

Our program is aimed at US-based primary care physicians (PCPs) who are looking to improve their knowledge and skills in CGM technology for patients with type 2 diabetes (T2D).

Meet the Faculty

Jennifer Green

Program Director

Jennifer Green, MD

Duke University
Durham, NC
United States

View Biography
Rozalina McCoy

Faculty Member

Rozalina McCoy, MD, MS

University of Maryland School of Medicine
Baltimore, MD
United States

View Biography
Eugene E. Wright

Faculty Member

Eugene E. Wright, Jr., MD

Duke University Medical Center
Durham, NC
United States

View Biography

Accreditation

In support of improving patient care, this program has been planned and implemented by the Postgraduate Institute for Medicine and Springer Healthcare IME. The Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the program. 

Planning Committee

In addition to the expert faculty, the Postgraduate Institute for Medicine and Springer Healthcare IME planners and staff include Holly Keatts, Judith Mitchek, Maria Glukhovsky, Elizabeth Samander, Alessandra Geffner-Smith, Jennifer Jett, and Kristen Rogers. The Planning Committee has no financial relationships to disclose.

All relevant financial relationships of the faculty have been mitigated.

Like this content? Share with a colleague

X-twitter Linkedin Facebook Envelope
© 2025 Springer Healthcare Limited. Part of Springer Nature Group.
X-twitter Linkedin Instagram Youtube
This site is intended for healthcare professionals only.
Funding

This activity is supported by an independent educational grant from Abbott.

Contact Us

Email: IME@springer.com

Springer Healthcare IME
1 FRD Drive, One New York Plaza
New York, 10004,
United States

Privacy Policy
Terms & Conditions
Manage Cookie Preferences
Jennifer Green

Program Director

Jennifer Green, MD

Duke University
Durham, NC
United States

Dr. Jennifer Green is a professor of medicine in the division of endocrinology at Duke University and a faculty member of the Duke Clinical Research Institute (DCRI). Her research has focused on strategies to treat diabetes and reduce the risks of cardiovascular, kidney, and other diabetes-related complications. Her work at the DCRI has included protocol development, oversight of adjudication committees, and clinical and operational leadership for several large international trials designed to determine the cardiovascular effects of glucose-lowering medications (TECOS, EXSCEL, and Harmony Outcomes). She currently serves as US coordinating center principal investigator (PI) and US national representative for the EMPA-Kidney trial of empagliflozin therapy in patients with chronic kidney disease. The EMPA-Kidney trial found that empagliflozin reduced the risk of a composite cardiorenal outcome in a broad spectrum of individuals with chronic kidney disease, with or without diabetes; a long-term, follow-up study of the participants is ongoing. 

Dr. Green is also part of the multidisciplinary leadership team for COORDINATE-Diabetes, a trial that was successful in increasing delivery of several guideline-based therapies (including high-intensity statin, angiotensin-converting enzyme inhibitor [ACEi]/angiotensin receptor blocker [ARB], and sodium-glucose cotransporter-2 inhibitor [SGLT2i] or glucagon-like peptide-1 receptor agonist [GLP-1RA]) to patients with type 2 diabetes (T2D) and atherosclerotic cardiovascular disease (ASCVD) who received care in cardiology clinics across the US. She is currently leading an innovative, centralized, site-less study of an intervention to reduce the risk of future diabetic foot ulceration, which will be conducted using an electronic health record (EHR)-linked software platform to assess clinical outcomes. 

Dr. Green has concluded three years of service as a member of the American Diabetes Association’s (ADA) Professional Practice Committee, which publishes the organization’s annual Standards of Care in Diabetes. She is now a member of the international ADA-EASD writing group that recently revised a joint consensus statement on the management of hyperglycemia in type 2 diabetes. 

Disclosures: 

  • Grant/research support: Merck, Roche, Lilly, Boehringer Ingelheim, Bluedrop
  • Consultant/advisory board: AstraZeneca, NovoNordisk, Pfizer, Bayer, Anji, Boehringer Ingelheim, Valo, Lilly, Vertex
Rozalina McCoy

Faculty Member

Rozalina McCoy, MD, MS

University of Maryland School of Medicine
Baltimore, MD
United States

Dr. Rozalina McCoy is an associate professor in the department of medicine’s division of endocrinology, diabetes, and nutrition, where she also serves as the associate division chief for clinical research, and the director of the precision medicine and population health program within the University of Maryland Institute for Health Computing. 

Dr. McCoy is a physician scientist who – through clinical care, research, and advocacy – is dedicated to improving the quality, accessibility, and sustainability of diabetes care. She is particularly interested in understanding and addressing the structural factors that lead to suboptimal care and poor health, with the goal of developing precision medicine tools and patient-centered care delivery models that improve health and wellbeing, while supporting the sustainability of the healthcare system. Dr. McCoy’s methodologic expertise is in the use of real-world data, including secondary analyses of administrative claims and electronic health record data; pragmatic point-of-care clinical trials; and population health research. She has been funded by the National Institutes of Health (NIH), the Patient-Centered Outcomes Research Institute, and the ADA, and has authored more than 160 peer-reviewed manuscripts. 

Dr. McCoy is passionate about caring for patients and serving her community, training the next generation of clinicians and applied researchers, and driving practice transformation to achieve better health outcomes with greater efficiency and lower cost. During her time at the Mayo Clinic (2015–2023), she led multiple efforts to improve care delivery through team-based primary care and community paramedicine. Dr. McCoy joined the University of Maryland family in August 2023 and enjoys working with faculty, students, and staff across the University of Maryland Baltimore, University of Maryland College Park (where she has an adjunct faculty position in the Department of Health Policy and Management of the University of Maryland School of Public Health), University of Maryland Baltimore County, University of Maryland Medical System (UMMS), and communities across Maryland to improve health through research, practice transformation, service, and education.

Disclosures: 

  • Consultant/advisory board: Emmi (Wolters Kluwer)
Eugene E. Wright

Faculty Member

Eugene E. Wright, Jr., MD

Duke University Medical Center
Durham, NC
United States

Dr. Eugene E. Wright, Jr. holds an appointment as consulting associate in the department of medicine of Duke University Medical Center. Dr. Wright has more than 40 years of clinical experience as a private practitioner, academic clinician and educator, medical administrator, a rural physician in southeastern NC, and a volunteer physician. From 2000 to 2013, he served in several roles within the Cape Fear Valley Health System, including medical director for primary care and speciality services and chief medical officer for the health system. He has worked with the South Piedmont Area Health Education Center (AHEC) on performance improvement since 2018. 

Dr. Wright serves as an associate editor of Clinical Diabetes and has served on several advisory and editorial boards, including Diabetes Technology & Therapeutics, and as a content reviewer for UpToDate. He served as the inaugural chair of the ADA Primary Care Interest Group, as a member of the ADA/AHA Know Diabetes by Heart Science Advisory Group, and in several leadership roles with the ADA Clinical Conference. Dr. Wright has published numerous articles on diabetes diagnosis and treatments and management and has given presentations at national and international meetings on new treatments and technology for diabetes. 

Dr. Wright has an undergraduate Bachelor of Science in Engineering (BSE) in electrical engineering from Princeton University (1973) and a medical degree from Duke University School of Medicine (1978). He completed his internship and residency in internal medicine at Duke University Hospital in 1981. 

Disclosures: 

  • Speakers bureau: Abbott Diabetes Care, Bayer, Boehringer Ingelheim, Eli Lilly, Sanofi
  • Consultant/advisory board: Abbott Diabetes Care, Bayer, Boehringer Ingelheim, Eli Lilly, Embecta, Sanofi, Medtronic
Close